DAR 0100A

Known as: DAR-0100A, DAR0100A 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2018
01220112018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
s for the Sixth Biennial SIRS Conference S240 Poster Session II 1MHO Rivierduinen; 2MHO North Holland North; 3Bureau Beta… (More)
Is this relevant?
2018
2018
s for the Sixth Biennial SIRS Conference S240 Poster Session II 1MHO Rivierduinen; 2MHO North Holland North; 3Bureau Beta… (More)
Is this relevant?
2016
2016
BACKGROUND Evidence from preclinical and human studies indicates the presence of reduced dopamine-1 receptor (D1R) signaling in… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
Pharmacological enhancement of prefrontal D1 dopamine receptor function remains a promising therapeutic approach to ameliorate… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2011
2011
DAR-0100A, the active enantiomer of dihydrexidine, is a potent dopamine D1 agonist under investigation for treatment of cognitive… (More)
Is this relevant?